Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001178913-12-003490
Filing Date
2012-12-21
Accepted
2012-12-21 10:13:15
Documents
12
Period of Report
2012-08-31

Document Format Files

Seq Description Document Type Size
1 10-K/A zk1212410.htm 10-K/A 69092
2 EXHIBIT 4.3 exhibit_4-3.htm EX-4.3 216841
3 EXHIBIT 10.7 exhibit_10-7.htm EX-10.7 14646
4 EXHIBIT 10.8 exhibit_10-8.htm EX-10.8 143365
5 EXHIBIT 10.19 exhibit_10-19.htm EX-10.19 266134
6 EXHIBIT 10.20 exhibit_10-20.htm EX-10.20 285866
7 EXHIBIT 10.23 exhibit_10-23.htm EX-10.23 221276
8 EXHIBIT 23.2 exhibit_23-2.htm EX-23.2 3855
9 EXHIBIT 31.3 exhibit_31-3.htm EX-31.3 4983
10 EXHIBIT 31.4 exhibit_31-4.htm EX-31.4 4908
11 malone2.jpg GRAPHIC 12355
12 nexia.jpg GRAPHIC 25990
  Complete submission text file 0001178913-12-003490.txt   1285219
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-K/A | Act: 34 | File No.: 000-50298 | Film No.: 121279504
SIC: 2834 Pharmaceutical Preparations